On average, results are ready in 3 to 4 weeks from when your sample is received with all required documentation from the ordering provider.
Q answer offers the most advanced tests for hereditary cancer. With a saliva sample, we are able to sequence and analyze the patient’s genetic material(DNA) to determine if any genetic changes exist that may increase the patient’s risk of a hereditary cancer syndrome. The data collected during testing is analyzed and translated into an easy to understand report. This report may be used by providers to help create personalized health management plans for their patients.
Genetic testing for hereditary cancer may determine which individuals were born with a predisposition to cancer. Identification of abnormal genes may provide information regarding cancer risks, best screening approaches, and well-informed health management recommendations. In other words, genetic testing may help to prevent cancer or aid in early diagnosis.
Negative Result: A negative test result means that the laboratory did not find the specific variant that the test was designed to detect. This result is most useful when a specific disease-causing variant is known to be present in a family. In such a case, a negative result can show that the tested family member has not inherited the variant that is present in their family and that this person therefore does not have the inherited cancer susceptibility syndrome tested for. Such a test result is called a true negative. A true negative result does not mean that there is no cancer risk, but rather that the risk is probably the same as the cancer risk in the general population. When a person has a strong family history of cancer but the family has not been found to have a known variant associated with a hereditary cancer syndrome, a negative test result is classified as an uninformative negative (that is, it typically does not provide useful information). In the case of a negative test result, it is important that the person’s doctors and genetic counselors ensure that that person is receiving appropriate cancer screening based on that person’s personal and family history and any other risk factors they may have. Even when the genetic testing is negative, some individuals may still benefit from increased cancer surveillance.
The Genetic Information Nondiscrimination Act of 2008 (GINA), is a Federal law that prohibits discrimination in health coverage and employment based on genetic information. GINA prohibits health insurers or health plan administrators from requesting or requiring genetic information of an individual or the individual’s family members or using their genetic information to make decisions regarding coverage, rates, or preexisting conditions under most circumstances. GINA also prohibits many employers from discriminating against employees based on their personal genetic information. Additional information about GINA may be found on the website: